Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 11;15(5):e091831.
doi: 10.1136/bmjopen-2024-091831.

PREgnancy Care Integrating translational Science, Everywhere (PRECISE): a prospective cohort study of African pregnant and non-pregnant women to investigate placental disorders - cohort profile

Collaborators, Affiliations

PREgnancy Care Integrating translational Science, Everywhere (PRECISE): a prospective cohort study of African pregnant and non-pregnant women to investigate placental disorders - cohort profile

Rachel Craik et al. BMJ Open. .

Abstract

Purpose: The PREgnancy Care Integrating translational Science, Everywhere Network was established to investigate specific placental disorders (pregnancy hypertension, preterm birth, fetal growth restriction and stillbirth) in sub-Saharan Africa. We created a repository of clinical and social data with associated biological samples from pregnant and non-pregnant women. Alongside this, local infrastructure and expertise in the field of maternal and child health research were enhanced.

Participants: Pregnant women were recruited in participating health facilities in The Gambia, Kenya and Mozambique at their first antenatal visit or at the time a placental disorder was diagnosed (Kenya and The Gambia only). Follow-up study visits were conducted in the third trimester, delivery and 6 weeks to 6 months postpartum. To elucidate the difference between pregnancy and non-pregnancy biology in these settings, non-pregnant nulliparous and parous women, aged 16-49 years, were recruited opportunistically primarily from family planning clinics in Kenya and Mozambique, and randomly through the Health and Demographic Surveillance System in The Gambia. Non-pregnant participants only had one study visit. Biological samples were processed rapidly and locally, stored initially in liquid nitrogen and then at -80°C, and details entered into an OpenSpecimen database linked to their social determinants and clinical research data.

Findings to date: A total of 6932 pregnant and 1825 non-pregnant women were recruited to the study, providing a repository of clinical and social data and a biorepository of 482 448 samples. To date, baseline descriptive analysis of the cohort has been undertaken, as well as a substudy on the prevalence of COVID-19 in the cohort.

Future plans: Analysis of data and samples will include an analysis of biomarker and social and physical determinants of health and how these interact in a systemic approach to understanding the origins of common placental disorders. The data from non-pregnant women will provide control data for comparison with the data from normal and complicated pregnancies. Findings will be disseminated to local stakeholders and communities through meetings and ongoing community engagement and globally by publication and presentations at scientific meetings.

Keywords: PUBLIC HEALTH; Pregnant Women; REPRODUCTIVE MEDICINE.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. Flow diagram of participants in the PRECISE cohort. Some of the postpartum follow-up visits in Kenya and The Gambia were conducted as part of the PRECISE-DYAD study. All the data collected in the PRECISE postpartum visit were collected at the DYAD visit. ANC, antenatal care; mo, months; NND, neonatal death; PRECISE, PREgnancy Care Integrating translational Science, Everywhere; TOD, time of disease; UNS, unselected pregnancy; wk, weeks; WRA, women of reproductive age. *Eighteen pregnancy outcome could not be classified.

References

    1. Ashorn P, Ashorn U, Muthiani Y, et al. Small vulnerable newborns—big potential for impact. The Lancet. 2023;401:1692–706. doi: 10.1016/S0140-6736(23)00354-9. - DOI - PubMed
    1. Geneva: World Health Organisation; 2023. Trends in maternal mortality 2000 -2020; estimates by WHO, UNICEF, UNFPA, world bank group and UNDESA/population division.
    1. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–33. doi: 10.1016/S2214-109X(14)70227-X. - DOI - PubMed
    1. Lawn JE, Ohuma EO, Bradley E, et al. Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting. The Lancet. 2023;401:1707–19. doi: 10.1016/S0140-6736(23)00522-6. - DOI - PubMed
    1. Firoz T, Vidler M, Makanga PT, et al. Community perspectives on the determinants of maternal health in rural southern Mozambique: a qualitative study. Reprod Health. 2016;13:112. doi: 10.1186/s12978-016-0217-x. - DOI - PMC - PubMed

LinkOut - more resources